Disseminated nontuberculous mycobacterial infections in sickle cell anemia patients

被引:15
作者
Thorell, Emily A.
Sharma, Mukta
Jackson, Mary Anne
Selvarangan, Rangaraj
Woods, Gerald M.
机构
[1] Childrens Mercy Hosp, Pediat Infect Dis Dept, Kansas City, MO 64108 USA
[2] Univ Missouri, Sch Med, Kansas City, MO 64110 USA
关键词
nontuberculous mycobacteria; sickle cell; hydroxyurea; Mycobacterium fortuitum; pulmonary disease;
D O I
10.1097/01.mph.0000243646.59111.28
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Nontuberculous mycobacteria (NTM) are ubiquitous in nature and have been implicated in skin/soft-tissue, pulmonary, middle ear, bone, and surgical/traumatic wound infections. Disseminated disease occurs infrequently and almost exclusively in the immunocompromised. We describe the first 2 reported cases of disseminated Mycobacterium fortuitum infection in teenagers with sickle hemoglobinopathy. Both had central venous catheters (CVCs), frequent admissions for vaso-occlusive painful episode and received hydroxyurea. Diagnosis was confirmed by multiple positive blood cultures and pulmonary dissemination occurred in both. Both had successful treatment after CVC removal and combination drug therapy. Positive cultures persisted in I patient due to drug resistance emphasizing the need for accurate susceptibility data. NTM infection should be added to the list of pathogens in sickle cell patients with CVCs and fever. Investigation for disseminated disease should be undertaken based on clinical signs and symptoms. Although some routine blood culture systems can identify NTM, specific mycobacterial blood culture is optimal. Removal of involved CVCs is essential and treatment of NTM must be guided by susceptibilities. As dissemination almost always occurs in those with impaired cellular immunity, human immunodeficiency virus testing should be performed. Hydroxyurea may be a risk factor for dissemination and needs further evaluation.
引用
收藏
页码:678 / 681
页数:4
相关论文
共 24 条
[1]   LONG-TERM CENTRAL VENOUS ACCESS IN PATIENTS WITH SICKLE-CELL DISEASE - INCIDENCE OF THROMBOTIC AND INFECTIOUS COMPLICATIONS [J].
ABDULRAUF, A ;
GAUDERER, M ;
CHIARUCCI, K ;
BERMAN, B .
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 1995, 17 (04) :342-345
[2]  
BLEI F, 1993, AM J PEDIAT HEMATOL, V15, P430
[3]   BROVIAC CATHETER-RELATED INFECTION DUE TO MYCOBACTERIUM-FORTUITUM IN A PATIENT WITH ACQUIRED-IMMUNODEFICIENCY-SYNDROME [J].
BRADY, MT ;
MARCON, MJ ;
MADDUX, H .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1987, 6 (05) :492-494
[4]  
CROSS JT, 1998, TXB PEDIAT INFECT DI, P1239
[5]   Prevention and management of infections in patients without a spleen [J].
Davidson, RN ;
Wall, RA .
CLINICAL MICROBIOLOGY AND INFECTION, 2001, 7 (12) :657-660
[6]  
Galassi L., 2003, Journal of Water and Health, V1, P133
[7]   Nontuberculous mycobacterial infections in hematopoietic stem cell transplant recipients: Characteristics of respiratory and catheter-related infections [J].
Gaviria, JM ;
Garcia, PJ ;
Garrido, SM ;
Corey, L ;
Boeckh, M .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2000, 6 (04) :361-369
[8]   NONTUBERCULOUS MYCOBACTERIA IN CHILDREN WITH ACQUIRED-IMMUNODEFICIENCY-SYNDROME [J].
HOYT, L ;
OLESKE, J ;
HOLLAND, B ;
CONNOR, E .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1992, 11 (05) :354-360
[9]   Central venous catheter complications in sickle cell disease [J].
Jeng, MR ;
Feusner, J ;
Skibola, C ;
Vichinsky, E .
AMERICAN JOURNAL OF HEMATOLOGY, 2002, 69 (02) :103-108
[10]  
Levendoglu-Tugal O, 1998, CLIN INFECT DIS, V27, P1227, DOI 10.1086/514981